Literature DB >> 2217149

Splenic amyloidosis: correlations between chemical types of amyloid protein and morphological features.

T Ohyama1, T Shimokama, Y Yoshikawa, T Watanabe.   

Abstract

Sixty-one autopsy cases of splenic amyloidosis were reviewed to assess the relationship between the morphological patterns and chemical types of amyloid protein. On the basis of immunohistochemical reactions of amyloid protein, the cases were classified into 34 cases of AA and 27 of AL amyloidosis. Amyloid deposition in the spleen was divided into three major sites: the red pulp, the white pulp, and blood vessels. Red pulp involvement by amyloid was noted in 52% of the AL cases but in none of the AA cases. White pulp amyloid deposition was found in 70% of the AL and 35% of the AA cases. This difference was statistically significant (P less than 0.001). On the other hand, vascular deposition of amyloid was invariably noted in all cases with AA or AL amyloidosis, affecting the AA cases rather severely. These results strongly suggest that the widely held concept of deposition of amyloid as predominantly vascular in AL amyloidosis and parenchymal in AA amyloidosis requires revision. Our findings indicate that parenchymal, especially the red pulp, involvement is a consistent feature of AL amyloidosis, whereas vascular involvement is a finding common to both types of systemic amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2217149

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  2 in total

1.  Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein.

Authors:  S Tada; M Iida; T Yao; T Kitamoto; T Yao; M Fujishima
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

2.  Visualization of multiple organ amyloid involvement in systemic amyloidosis using 11C-PiB PET imaging.

Authors:  Naoki Ezawa; Nagaaki Katoh; Kazuhiro Oguchi; Tsuneaki Yoshinaga; Masahide Yazaki; Yoshiki Sekijima
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-10       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.